The TB-500/BPC-157 Blend combines two of the most researched peptides in regenerative science — TB-500 (10mg) and BPC-157 (10mg) — into a single lyophilized research formulation. This dual-peptide blend is designed for studies exploring synergistic mechanisms in tissue repair, angiogenesis, and wound healing.
Clinical Research Overview
- TB-500 (Thymosin Beta-4 Fragment, Ac-SDKP): Promotes actin polymerization and cell migration via G-actin sequestration; activates integrin-linked kinase (ILK) and PI3K/Akt signaling; upregulates VEGF and eNOS for angiogenesis in cardiac and soft tissue injury models
- BPC-157 (Body Protective Compound-157, GEPPPGKPADDAGLV): Systemic cytoprotective pentadecapeptide; activates nitric oxide and VEGF pathways for vascular repair; demonstrated protective and regenerative effects in gastrointestinal, tendon, ligament, and neural models
- Synergistic combination: preclinical data suggests complementary mechanisms — TB-500 driving cell migration and TB-500/BPC-157 together accelerating vascularization and matrix remodeling in wound models
Blend Components
- TB-500: MW 4963.5 Da; sequence Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES; purity >=99% HPLC
- BPC-157: MW 1419.5 Da; sequence GEPPPGKPADDAGLV; purity >=99% HPLC
- Both components lyophilized and co-formulated per vial; Certificate of Analysis included
Available for Research
- TB-500/BPC-157 Blend - 1 Pack (TB-500 10mg + BPC-157 10mg per vial)
Storage and Handling
- Store lyophilized at 2-8 degrees Celsius, protected from light
- Reconstituted solution: use within 7 days at 2-8 degrees Celsius
- Ships with cold chain packaging
- For research use only — not for human consumption